- Home
- MNTK vs XERS Comparison
MNTK vs XERS Comparison
Compare MNTK & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- XERS
- Stock Information
- Founded
- MNTK 1980
- XERS 2005
- Country
- MNTK United States
- XERS United States
- Employees
- MNTK N/A
- XERS N/A
- Industry
- MNTK Natural Gas Distribution
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- MNTK Utilities
- XERS Health Care
- Exchange
- MNTK Nasdaq
- XERS Nasdaq
- Market Cap
- MNTK 622.2M
- XERS 628.7M
- IPO Year
- MNTK 2021
- XERS 2018
- Fundamental
- Price
- MNTK $2.36
- XERS $5.16
- Analyst Decision
- MNTK Hold
- XERS Strong Buy
- Analyst Count
- MNTK 3
- XERS 5
- Target Price
- MNTK $3.33
- XERS $6.10
- AVG Volume (30 Days)
- MNTK 155.1K
- XERS 2.3M
- Earning Date
- MNTK 05-08-2025
- XERS 05-08-2025
- Dividend Yield
- MNTK N/A
- XERS N/A
- EPS Growth
- MNTK N/A
- XERS N/A
- EPS
- MNTK 0.07
- XERS N/A
- Revenue
- MNTK $175,736,000.00
- XERS $222,551,000.00
- Revenue This Year
- MNTK $4.25
- XERS $31.75
- Revenue Next Year
- MNTK $23.36
- XERS $21.09
- P/E Ratio
- MNTK $34.50
- XERS N/A
- Revenue Growth
- MNTK 0.48
- XERS 29.88
- 52 Week Low
- MNTK $1.75
- XERS $1.72
- 52 Week High
- MNTK $6.22
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- MNTK 49.44
- XERS 63.30
- Support Level
- MNTK $2.09
- XERS $4.26
- Resistance Level
- MNTK $2.27
- XERS $4.77
- Average True Range (ATR)
- MNTK 0.14
- XERS 0.28
- MACD
- MNTK 0.04
- XERS 0.08
- Stochastic Oscillator
- MNTK 69.39
- XERS 91.32
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).